Prof C. Oliver Kappe is Professor of Chemistry at the University of Graz (Austria) and Scientific Director of the Center for Continuous Flow Synthesis and Processing (CCFLOW) at the Research Center Pharmaceutical Engineering GmbH (RCPE). He received his diploma (1989) and his doctoral (1992) degrees in organic chemistry from the University of Graz where he worked with Gert Kollenz on cycloaddition and rearrangement reactions of acylketenes. After periods of postdoctoral research work on reactive intermediates and matrix isolation spectroscopy with Curt Wentrup at the University of Queensland in Brisbane, Australia (1993-1994) and on synthetic methodology/alkaloid synthesis with Albert Padwa at Emory University in Atlanta, USA (1994-1996), he moved back to the University of Graz in 1996 to start his independent academic career. He obtained his „Habilitation“ in 1998 in organic chemistry and was appointed Associate Professor in 2000. Since 2011 he is Professor for „Technology of Organic Synthesis“ (Organische Synthesetechnologie) at the Institute of Chemistry at the University of Graz. He has spent time as visiting scientist/professor at e.g. the Scripps Research Institute (La Jolla, USA, K. Barry Sharpless, 2003), the Toyko Institute of Technology (Toyko, Japan, T. Takahashi, 2008), the Sanford-Burnham Institute for Medical Research (Orlando, USA, 2010) and the Federal University of Rio de Janeiro (Rio de Janeiro, Brazil, 2013-2015).

Professor Kappe has an extensive general experience and a more than 30 year track record in synthetic and physical organic chemistry, process intensification using batch microwave technology and flow chemistry/microreaction technology, communicated in ~450 scientific publications (Publons, WoS h-Index 80; 2018 Clarivate Analytics Highly Cited Researcher). For the past decade the focus of his research has been directed towards flow chemistry/microreaction technology, encompassing a wide variety of synthetic transformations and experimental techniques. His research group is actively involved in projects dealing with API synthesis and sustainable manufacturing, employing a number of different enabling and process intensification technologies. For his innovative work in microwave chemistry he received the 2004 Prous Science Award from the European Federation for Medicinal Chemistry and the 2010 100.000 € Houska Prize, in addition to a number of other awards. In 2015 he was named Fellow of the Royal Society of Chemistry. In 2018 is received the IUPAC-ThalesNano Award in Flow Chemistry.

Prof. C. Oliver Kappe is the Founding Editor (Editor-in-Chief from 2011-2018) of the Journal of Flow Chemistry (Springer) and a board member of the Flow Chemistry Society. He currently serves as an Editor for Chemistry-Methods (Wiley) and has been an Editor of the Journal QSAR and Combinatorial Sciences (Wiley-VCH, 2003-2007). In addition he serves on the Editorial/Advisory Boards of Green Chemistry, Reaction Chemistry & Engineering (RSC), Organic Process Research & Development (ACS), and Current Opinion in Green and Sustainable Chemistry (Elsevier). For several years he has been teaching courses on flow chemistry for Scientific Update.

Dr Christophe Len received his Ph.D. from the University of Picardie-Jules Verne (UPJV) in Amiens (France) under the supervision of Professor P. Villa in the field of carbohydrate chemistry. In 1996, he joined Doctor G. Mackenzie\'s group at the University of Hull (UK) as a post-doctoral fellow to work on the synthesis of nucleoside analogues. In 1997, CL became Assistant Professor at the Laboratoire des Glucides of UPJV and worked on the chemistry of antiviral nucleoside analogues specialising on those with novel glycone systems. In 2003, CL received his habilitation and was promoted to full Professor in 2004 at the University of Poitiers (France) where he was the supervisor of the team \"Biomolecules: Synthesis and Molecular Organization\". For 2008, CL had a secondment to the University of Technology of Compiègne - UTC (France) where he created a new scientific team called \"Organic Chemistry and Alternative Technologies\" with the perspective to develop research activity on green chemistry and sustainable development. In 2010, CL became full Professor at the University of Compiègne - UTC (France). Since November 2017, CL has developed his research at Chimie ParisTech (France) in the group \"Catalysis, Synhesis of Biomolecules and Sustainable Development\". Dr CL is a member of the french Research Network GDR2053 CNRS \"Continuous Flow Chemistry\". 

The principle interests of Dr Len\'s research are organic synthesis including: (i) the reactivity of biomass-derived molecules (glycerol, fatty acids, lignin, cellulose) for the formation of new chemical bonds; (ii) carbon-carbon cross coupling reactions (Suzuki-Miyaura, Tsuji-Trost reactions…) catalyzed by palladium complexes in aqueous media with or without ligand; (iii) homogeneous, heterogeneous and micellar catalysis using either commercial surfactants or new bio-based ones; (iv) the use of unconventional media (water, critical fluids, ionic liquids); (v) the use of alternative methods such as microwave irradiation, ultra-sounds, photochemistry, continuous flow.

His scientific work has been published in ca. 200 original international publications and review articles, 8 chapters and 10 patents including publications in high profile journals such as Chem. Rev., Energy Environ. Sci., Coord. Chem. Rev., ChemSusChem., Green Chem., Chem. Commun., J. Med. Chem., Chem. Asian J., J. Org. Chem.

Dr Lee Edwards has accumulated 25 years of experience within the pharmaceutical industry. He joined Sandoz Pharma AG / Novartis in 1995, he joined Maybridge Chemical Company Ltd in 1998. as a research chemist where he performed custom syntheses of fine chemicals up to 10 L scale. He re-joined Novartis in 2000 and worked on various medicinal chemistry targets where he simultaneously pioneered technologies emerging at that time (microwave chemistry, dynamic combinatorial chemistry, flow chemistry). His contributions at Novartis led to two compounds in the clinic, including Icenticaftor due to market in 2024 and saw him become one of its global industrial experts in photochemistry. He joined GSK in 2014 as a Process Chemist where he supported various internal API development projects on single and multi‐stage continuous flow steps, and represents the company in various industry‐academia collaboration projects. He developed GSK’s global photochemical platform and in his current role is responsible for gas/liquid trickle bed flow chemistry. He is listed as author/inventor on 61 publications/patent applications.

Prof. Ferenc Darvas acquired his degrees in Budapest, Hungary (medicinal chemistry MS, computer sciences BS, PhD in experimental biology). He has been teaching in Hungary, Spain, Austria, and in the USA. Dr. Darvas has been involved in introducing microfluidics/flow chemistry methodologies for synthetizing drug candidates since the late 90’s, which led him to found ThalesNano, the inventor of H-Cube®, and has been awarded three times with R&D100 (“Technical Oscar”).

Dr. Darvas was awarded Senator Honoris Cause by the University of Szeged, Hungary (2019), and as Fellow of the American Chemical Society (2016). Dr. Darvas is also the founder and active President of the Flow Chemistry Society, Switzerland, founder and Editorial Board member of the Journal of Flow Chemistry, founder of the Space Chemistry Consortium, organizer of the Space Chemistry Symposium series at ACS, and initiator of the world-first anti-Covid drug discovery experiments on ISS.

Dr Tarver studied at the University of Sheffield and completed his PhD under the supervision of Varinder K. Aggarwal in 1997. His first appointment was as a medicinal chemist at Organon labs at Newhouse, Scotland. In 2004 he moved into a scale up and optimisation role leading a team of chemists in scale up, route evaluation, reaction optimisation and technology development. In 2010 he moved to Cyclofluidic Ltd. where he worked to develop the flow chemistry portion of a fully automated closed-loop flow chemistry system. In 2017 he moved to NewPath molecular developing flow chemistry methods and chemical automation. In 2018 he moved to the Drug Discovery Unit of the University of Dundee where he is Team Leader of the Synthetic Methodologies team which covers roles such as flow chemistry, scale up chemistry, plate based chemistry and new technologies.

Dr Marcus Baumann graduated from Philipps-University Marburg (Germany) in 2007 before moving to Cambridge/UK to study for a PhD with Prof. Steven V. Ley FRS. On completion of his PhD in 2010 he was awarded a Feodor-Lynen postdoctoral fellowship by the Humboldt foundation allowing him to join the research group of Prof. Larry E. Overman at the University of California in Irvine. After two years in Irvine, he returned to the UK to work with Prof. Ian R. Baxendale at the University of Durham applying flow methodology to the scaled synthesis of biologically relevant chemical entities.

In 2017 he became an Assistant Professor for Continuous Flow Chemistry at University College Dublin, where his group’s efforts centre around the development of new continuous flow methods applied to the effective generation of various target molecules. In 2021 he was a Visiting Professor at the University of Toronto. Current areas of interest include process development, reaction scale-up, photochemistry, telescoped multi-step sequences and flow biocatalysis.

Mr. Vijay Kirpalani, Founder President, Flow Chemistry Society – India Chapter has obtained his B.E. (Chemical Engg.) from Maharaja Sayajirao University, Baroda. He is also a CEO, Pi-Process Intensification Experts LLP; Director of Sharon Bio-Medicine Ltd. As well as ChemSphere Consultants P. Ltd.; Partner, ChemSphere Technologies and Director, Mehta API (P) Ltd.
He is expert in Process Intensification, Flow Chemistry, Bio-catalysis, Process Design & Execution (of cGMP HAPI / API / Pharma Formulation, Chemical, Fine-Chemical, Biotech & Nanotech Facilities), QbD, PAT, Reg Affairs. He has Experience with an extensive repertoire of process technologies that have been developed and commercialized across over 100 grass-roots plants with > 200 processes in 14 countries.
In 2012, he conceived the scheme and led the Team as Director & Head – receiving a Grant of Rs. 6.9o Cr from DSIR (under the Technology-Development&Demo Programme) for development of Enzymes and Chemo-enzymatic methods to Chiral APIs & Intermediates including setting-up of a state-of-the-art biotech laboratory.
He had also Worked with BARC (Bhabha Atomic Research Center), Bharat Petroleum, IPCL, United Phosphorous Ltd., Baroda Productivity Council, etc.

Dr. Srividya Ramakrishnan heads Process Engineering(API) at Dr. Reddy’s Laboratories Ltd. in Hyderabad.She earned her B.Tech. in Chemical Engineering from Indian Institute of Technology, Madras, and Ph.D. from Princeton University, USA. Prior to joining Dr. Reddy’s, she worked at Unilever Research followed by Bristol-Myers Squibb in New Jersey. Srividyahas brought in innovative, continuous manufacturing technologies that would enable greater sustainability with lower cost. She has presented her research at international conferences, has several patents and publications to her credit and is also an ASQ-Certified Six Sigma Black Belt. Since last year, she has taken up an additional role as Chief Diversity Officer at Dr. Reddy’s. Srividya is passionate about women’s empowerment and was instrumental in drafting policies to enable work-life integration (recognized for Leadership Commitment at UN Women India 2020 WEPs awards).

Prof Tanja Junkers graduated with a PhD degree in physical chemistry from Goettigen University in Germany in 2006, having worked on the determination of kinetic rate coefficients for radical reactions during polymerizations. Following that she was a research associate at the University of New South Wales in Sydney. Between 2008 and 2010 she was appointed as senior research scientist at the Karlsruhe Institute of Technology in Germany. Early 2010 she was then became professor at Hasselt University in Belgium, where she founded the Polymer Reaction Design group. 2018 she joined Monash University in Australia as full professor, focusing on her work on continuous flow polymerizations, digitization of chemistry, (nano)particle formation and design of complex precision polymers. She has published over 200 articles and is a thought leader in the field of polymer synthesis in continuous flow.

Dr. Sandeep Jain, Associate Vice President, at Sun Pharmaceutical is heading the Flow Chemistry Lab & Process Development Division. He received PhD in Organic Chemistry from Jiwaji University, Gwalior, India.  He has an extensive industrial experience of 23 years in leading pharma based organizations including Aurobindo Pharma, Jubilant Life Sciences, Torrent Research Centre and Ind-Swift Labs. He is an expert of continuous flow chemistry, process development, process safety and crystallization techniques. He had started a dedicated flow chemistry lab at his previous and current organization and scaled up many projects at commercial scale.

Dr Mike Kenny is the Business Development Manager at AM Technology, who manufacture the Coflore range of continuous flow reactors.
Dr Kenny graduated with a PhD degree from the University of Bath in 2018, having worked on the synthesis of highly cytotoxic cyclopropabenzindoles, as part of a project funded by Prostate Cancer UK under the supervision of Prof. Michael D. Threadgill. Today, Dr Kenny works with the chemical industry to both bring new chemical processes, and convert existing batch processes, into continuous manufacture.

Dr Stephen Hilton is an Associate Professor at UCL school of Pharmacy, having previously worked as an academic fellow at the School of Pharmacy, University of London.

He carried out postdoctoral research at the Institute of Cancer Research (ICR) and with Professor William Motherwell at UCL. Dr Hilton\\\'s diverse research interests range from medicinal chemistry, scale-up synthesis and new technology with an emphasis on the applications of 3D printing and Virtual Reality in Synthetic Chemistry and Pharmaceutical applications. Dr Stephen Hilton is the Inventor of the IKA FLOW - continuous flow reactor, which is partnered and sold by IKA.

Mr Divyanshu is responsible for managing sales, business development & S&A for Gorilla Glass and a portfolio of emerging business for Corning India. He leads the sales and application engineering team for Corning Advanced Flow Reactor in India. He also worked on a successful industrialization of Corning G4 reactor at a leading India pharmaceutical company. Under his leadership, Corning Advanced Flow reactor has grown its presence in the last two years.

Mr Divyanshu joined Corning India in October 2012 and has held positions in strategy, business development, sales, and S&A management.

Before joining Corning, he was a Senior Consultant with KPMG in their strategy practice in India for 4.5 years.

Mr Divyanshu holds B.Tech. from Indian Institute of Technology (IIT), Kharagpur and MBA from the Indian School of Business (ISB) at Hyderabad.

Dr. Vishwanath H. Dalvi is a chemical engineering faculty at the Institute of Chemical Technology, Mumbai. His vision is for India to be a resilient, secure, knowledge-based economy. His research focuses on sustainable development and economic empowerment. To that end, he works on developing technologies that are imperatively decentralized e.g., micro CSP power generation, waterless toilets, novel biogas generators and open-source process engineering tools. He is known to be an excellent teacher having won awards for teaching both from the Institute of Chemical Technology and from the All-India Council of Technical Education. He is currently consulting Amar equipment on process and reactor development in the field of flow chemistry. He is also very passionate about coffee, cookies and cats.

Dr. Manuel Nuño completed his MChem at Universidad de Zaragoza, Spain and York University, UK moving to University of Bath, UK to undertake his PhD in photocatalysis under the supervision of Dr Richard J. Ball.

Following completion of his PhD, Manuel advanced his process improvement skills during three years as process development chemist in food manufacturing industry working to improve the performance of large scale batch and flow chemical processes involving extraction, purification and crystallisation of sugars. Currently Manuel works at Vapourtec ltd as Chief Scientific Officer, offering applications and chemistry support to customer and product development teams. Projects he has worked with include, photochemistry in flow, flow peptide synthesis, organometallic chemistry in flow and continuous electrochemical oxidation of natural products.

Chandrakant is Manager Sales, Advanced-Flow Reactors (AFR), Corning Reactor Technologies, Corning India where he is responsible for growth and driving the Flow Reactors market to generate potential new business opportunities with a focus on flow technologies.

Chandrakant has been with Corning Reactor Technologies for over eight years and has 16+ years of broad and diverse experience in developing market for new products in reactors and mixing technologies for Pharmaceutical and Specialty Chemical companies. His key focus area is to develop markets for the adoption of continuous flow technologies from lab to production.

Chandrakant holds a B. Tech in Chemical Engineering from North Maharashtra University, Department of Chemical Technology (UDCT).

Mr Shekhar is an Application Engineer, Corning Advanced Flow Reactor Technology, Corning India where he is responsible for application part like chemistry optimization, reactor installation and commissioning and training.

Mr Shekhar has seven years of industry experience and has been with Corning since 2016. His expertise lies in Flow Chemistry and scale up in continuous flow synthesis, chemical process engineering, and process enhancement. He has also published two papers on continuous flow synthesis on microreactor.

Mr Shekhar has a bachelor’s degree in Chemical Engineering from Dr. Babasaheb Ambedkar Technology University, Lonere, and a master’s degree in Chemical Engineering from the National Institute of Technology, Warangal.

Dr Kishan received his Ph.D (Catalysis) from  IICT- Hyderabad in 1997.  He did his post-doc at International Universities in South Korea (1997-98), The Netherlands (1999-2000) and was also visiting scientist at University of Ulm, Germany. Dr Kishan has started his career with GE India Tech. Center, Bangalore in 2000, and became Technical Director in 2009. He became Global Technology Leader for Aromatics & chloro-alkali in 2012 (Geleen, Netherlands) and Managing Director, STC Bengaluru (~350+ team) & Board of Director for SRTPL during 2014-2019.

In 2019, he has founded 2 new companies “Sravathi Advance process Technologies Pvt Ltd & Sravathi AI Technology Pvt Ltd”. He is presently Founder, MD & CEO and also Board of director for both Sravathi companies. His team (~150+ people) working on cutting edge Sravathi AI platform for chemistry and flow chemistry.

Dr Kishan’s work in monomers and catalysis have been significant in commercialization of various projects in GE /SABIC. Dr Kishan has received many accolades over the years, such as CV Raman Innovation Award (2006), Most valuable player award (2008), Supper achiever award (2002), Gold patent award and >20 Management awards received from GE/SABIC. Dr Kishan has 35 publications, 25 conference papers and >50 are granted patents to his credential.  He was invited speaker in National & International conferences. He is also Ph.D thesis examiner and referee for International journals.